Identifying the Right CDMO to Support Biopharma Manufacturing

EP: 1.New Opportunities via Novel Formulation Technologies

Now Viewing

EP: 2.Identifying the Right CDMO to Support Biopharma Manufacturing

EP: 3.Optimizing Drug Delivery Methods With Nanotechnologies

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:

• What to look for when identifying a CDMO for a drug development project
• Ascendia Pharmaceuticals and its expansion of manufacturing services
• Ascendia Pharmaceuticals as a "Partner of Choice"